Percutaneous nephrolithotomy (PCNL) has been a popular treatment option for kidney stones since its development in the 1970s. It is a minimally invasive procedure that involves making a small incision in the patient's back and inserting a tube into the kidney to remove the stone. The procedure has been successful in treating larger stones that cannot be treated with other methods, such as shockwave lithotripsy. However, PCNL has also been associated with a number of risks, including infection, bleeding, and pain. Recently, advances in technology have allowed for a new type of PCNL, known as Outpatient Ureteroscopy and Nephrolithotomy (OUSN). This procedure is less invasive than traditional PCNL and has a lower risk of complications. In this article, we will discuss the advantages of OUSN and how it is revolutionizing the treatment of kidney stones.
OUSN is a minimally invasive procedure that combines ureteroscopy and nephrolithotomy. Ureteroscopy is a procedure in which a flexible scope is inserted through the urethra and bladder into the ureter, the tube that connects the kidney to the bladder. Through this scope, the doctor can see the stone and remove it with a basket-like device. Nephrolithotomy is a procedure in which a small incision is made in the patient's back and a tube is inserted into the kidney to remove the stone. With OUSN, the ureteroscopy and nephrolithotomy are performed in one procedure, which reduces the risk of complications and allows for a shorter recovery time.
OUSN has several advantages over traditional PCNL. First, OUSN is less invasive than PCNL, which means it has a lower risk of complications. Additionally, OUSN does not require general anesthesia, which reduces the risk of anesthesia-related complications. Finally, OUSN has a shorter recovery time than PCNL, allowing patients to return to their normal activities sooner.
OUSN is becoming increasingly popular among doctors as a way to treat kidney stones. Studies have shown that OUSN is as effective as traditional PCNL in treating larger stones, but with fewer complications and a shorter recovery time. Additionally, OUSN is often less expensive than PCNL, making it a more cost-effective option.
OUSN is a revolutionary new procedure that is revolutionizing the treatment of kidney stones. It is less invasive than traditional PCNL and has a lower risk of complications and a shorter recovery time. Additionally, OUSN is often more cost-effective than PCNL. As OUSN becomes more widely available, it is likely to become the preferred method of treating kidney stones.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Lung Transplant for Lung Cancer: Promising, in Rare Cases
3.
Rural-urban disparities seen in cervical cancer
4.
Obesity linked to subsequent neoplasms in childhood cancer survivors
5.
New policy review highlights the importance of health-related quality of life in advanced cancer
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
3.
Is AI The New Radiologist For Breast MRI?
4.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
5.
Bone Marrow Regeneration in Hematologic Recovery
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation